Investor Relations

Stock price graph

GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.

For investor information, please contact IR@genmarkdx.com.

Annual Reports

2014 Proxy Statement

2013 Annual Report

2013 Proxy Statement

2012 Annual Report

2011 Annual Report

2012 Proxy Statement


Recent Releases

Aug 11, 2014
GenMark Diagnostics Reports Second Quarter 2014 Results

Aug 11, 2014
GenMark Diagnostics Appoints Dr. James Fox as Chairman of the Board

View all releases »

Events

Aug 13, 2014 at 9:30 AM ET
Canaccord Genuity 34th Annual Growth Conference

Aug 11, 2014 at 4:30 PM ET
GenMark Diagnostics Second Quarter Earnings

View all events »

Related Links

Stock Quote
Price:
10.75
Change:
+ 0.09
Day High:
10.79
Day Low:
10.63
Volume:
157,500
NASDAQ
GNMK
4:00 PM ET on Aug 29, 2014
Delayed at least 20 minutes.
Provided by eSignal.